Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13641 | 759 | 30.4 | 44% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
389 | 16325 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DISSOLUCYTOSIS | Author keyword | 7 | 64% | 1% | 7 |
2 | METALLIC GOLD | Author keyword | 6 | 58% | 1% | 7 |
3 | AURANOFIN | Author keyword | 4 | 17% | 3% | 20 |
4 | AUROTHIOMALATE | Author keyword | 4 | 30% | 1% | 10 |
5 | GOLD ACUPUNCTURE | Author keyword | 2 | 67% | 0% | 2 |
6 | MYOCHRYSINE | Author keyword | 2 | 67% | 0% | 2 |
7 | GOLD SODIUM THIOMALATE | Author keyword | 2 | 22% | 1% | 8 |
8 | ANTIRHEUMATIC DRUGS | Author keyword | 2 | 17% | 1% | 9 |
9 | CHRYSOTHERAPY | Author keyword | 2 | 33% | 1% | 4 |
10 | CITIRAZINE | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DISSOLUCYTOSIS | 7 | 64% | 1% | 7 | Search DISSOLUCYTOSIS | Search DISSOLUCYTOSIS |
2 | METALLIC GOLD | 6 | 58% | 1% | 7 | Search METALLIC+GOLD | Search METALLIC+GOLD |
3 | AURANOFIN | 4 | 17% | 3% | 20 | Search AURANOFIN | Search AURANOFIN |
4 | AUROTHIOMALATE | 4 | 30% | 1% | 10 | Search AUROTHIOMALATE | Search AUROTHIOMALATE |
5 | GOLD ACUPUNCTURE | 2 | 67% | 0% | 2 | Search GOLD+ACUPUNCTURE | Search GOLD+ACUPUNCTURE |
6 | MYOCHRYSINE | 2 | 67% | 0% | 2 | Search MYOCHRYSINE | Search MYOCHRYSINE |
7 | GOLD SODIUM THIOMALATE | 2 | 22% | 1% | 8 | Search GOLD+SODIUM+THIOMALATE | Search GOLD+SODIUM+THIOMALATE |
8 | ANTIRHEUMATIC DRUGS | 2 | 17% | 1% | 9 | Search ANTIRHEUMATIC+DRUGS | Search ANTIRHEUMATIC+DRUGS |
9 | CHRYSOTHERAPY | 2 | 33% | 1% | 4 | Search CHRYSOTHERAPY | Search CHRYSOTHERAPY |
10 | CITIRAZINE | 1 | 100% | 0% | 2 | Search CITIRAZINE | Search CITIRAZINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SODIUM THIOMALATE | 15 | 48% | 3% | 23 |
2 | CHRYSOTHERAPY | 8 | 33% | 3% | 19 |
3 | OCULAR CHRYSIASIS | 6 | 100% | 1% | 4 |
4 | GOLD SODIUM THIOMALATE | 4 | 18% | 3% | 21 |
5 | SERUM GOLD | 4 | 75% | 0% | 3 |
6 | STROKE LIKE SYNDROME | 4 | 75% | 0% | 3 |
7 | ANTI RHEUMATIC DRUGS | 3 | 50% | 1% | 5 |
8 | BEAD IMPLANTATION | 3 | 100% | 0% | 3 |
9 | AURANOFIN | 3 | 11% | 3% | 26 |
10 | METALLIC GOLD | 3 | 29% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Auranofin | 1997 | 69 | 56 | 55% |
Molecular mechanisms of action of gold treatment in rheumatoid arthritis - an update | 2001 | 18 | 14 | 64% |
Chrysotherapy: a synoptic review | 2003 | 55 | 85 | 33% |
GOLD INDUCED ENTEROCOLITIS | 1986 | 26 | 10 | 100% |
THE GOLD COMPLEXES | 1990 | 37 | 136 | 49% |
AURANOFIN - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN RHEUMATOID-ARTHRITIS | 1984 | 59 | 76 | 87% |
Nitritoid reactions: Case reports, review, and recommendations for management | 2001 | 1 | 9 | 89% |
Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: A case report and review of the literature | 1999 | 2 | 14 | 86% |
The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines | 1997 | 72 | 243 | 17% |
CLINICAL PHARMACOKINETICS OF ORAL AND INJECTABLE GOLD COMPOUNDS | 1986 | 18 | 11 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNV KLINIKUM CHARITE | 1 | 50% | 0.1% | 1 |
2 | SECT NEUROPROTECT | 0 | 11% | 0.5% | 4 |
3 | DENT INTERNAL MED | 0 | 33% | 0.1% | 1 |
4 | SERV BIOCHIM TOXICOL | 0 | 25% | 0.1% | 1 |
5 | CHILDRENS HOSP MED MED | 0 | 17% | 0.1% | 1 |
6 | RHEUMAZENTRUM RHEIN MAIN | 0 | 17% | 0.1% | 1 |
7 | INTERDISCIPLINARY HUMAN TOXICOL PROGRAM | 0 | 11% | 0.1% | 1 |
8 | NEUROSCI PHARMACOL HLTH SCI | 0 | 11% | 0.1% | 1 |
9 | CARDIAC SURGST MARYS HOSP | 0 | 100% | 0.1% | 1 |
10 | DCAV | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000209503 | GOLDIII COMPLEXES//SULFANYLPROPENOIC ACIDS//GOLD COMPLEXES |
2 | 0.0000129200 | D PENICILLAMINE//MESANGIAL GLOMERULOPATHY//ANTIACETYLCHOLINE RECEPTOR ANTIBODIES |
3 | 0.0000111735 | SULFASALAZINE//SULPHASALAZINE//2ND LINE AGENT |
4 | 0.0000110526 | METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68 |
5 | 0.0000104420 | BUCILLAMINE//LOBENZARIT//ANTIRHEUMATIC DRUG |
6 | 0.0000102909 | GOLD SODIUM THIOSULFATE//POTASSIUM DICYANOAURATE//SYSTEMIC PROVOCATION |
7 | 0.0000098058 | STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE |
8 | 0.0000078085 | CHAIR PEDIAT CARDIOL 2//SYNOVIAL MEMBRANES//CLIN GRP 3 |
9 | 0.0000071534 | TENIDAP//TEPOXALIN//TENIDAP SODIUM |
10 | 0.0000068971 | ARGYRIA//ARGYROSIS//5 5 DITHIOBIS |